Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the publication ...
As the FDA unveils a parade of initiatives aimed at accelerating drug development for rare diseases, experts appeal for a ...
News Medical on MSN
Doctors warn about cardiovascular dangers from excessive energy drink use
Downing several strong energy drinks every day may pose a serious stroke risk, doctors have warned in the journal BMJ Case ...
The milestone was earned when Arrowhead achieved the second development milestone event in a Phase 1/2 clinical study of ARO-DM1, also called SRP-1003, an investigational RNA interference ("RNAI") ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared progress in the Phase 1/2 multiple ascending dose ...
Despite modern scientists identifying mercury as a hazardous environmental pollutant and one of the world 39;s most dangerous elemental toxins, mercury was once accepted as a miraculous substance ...
A recent case study highlights a serious stroke risk linked to excessive energy drink consumption. A man who drank eight ...
Failing to do so could result in a fine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback